Clinical Trials Browser

Phase 2 × Interventional × KPNA1 protein, human × Clear all

NCT02302339 2019-09-06

A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma

Phase 2 Terminated

132 enrolled 16 charts

Melanoma, Skin Neoplasms

NCT02351037 2018-08-14

Study of Ibrutinib in Subjects With Acute Myeloid Leukemia

Phase 2 Terminated

36 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute